T-BAM/CD40-L on Helper T Lymphocytes Augments Lymphokine-induced B Cell Ig Isotype Switch Recombination and Rescues B Cells from Programmed Cell Death
Overview
Authors
Affiliations
An important component of T cell help for B lymphocyte differentiation is the contact-dependent signaling mediated by the T cell-B cell activating molecule (T-BAM/CD40-L), an activation-induced surface membrane protein on CD4+ T helper cells in lymphoid follicles that interacts with the B cell surface molecule, CD40. The present study dissects the roles of T-BAM/CD40-L in helper function by means of a neutralizing anti-T-BAM/CD40-L mAb (5c8), a T-BAM/CD40-L-expressing T cell tumor subclone (Jurkat D1.1), and a T-BAM/CD40-L-responsive IgM+ B cell tumor of germinal center origin (RAMOS 266). Like activated T cells, D1.1 cells induce B cells to synthesize IgG, IgA, and IgE in a process that is specifically inhibited by the mAb 5c8. Although rIL-4 alone, but not Jurkat D1.1, induces IgH C gamma mRNA transcripts in RAMOS 266, the T-BAM/CD40-L molecule on D1.1 acts on rIL-4-primed RAMOS B cells to augment expression of C gamma transcripts. In addition, IgG+ RAMOS 266 clones were expanded from D1.1- and rIL-4-stimulated cultures that had undergone deletional IgH isotype switch recombination events. Furthermore, T-BAM/CD40-L signals delivered by the D1.1 clone dramatically rescue RAMOS 266 from mAb anti-IgM-induced apoptosis. Taken together, these data support the idea that T-BAM/CD40-L plays important roles in inducing Ig isotype switch recombination and the clonal selection of isotype-switched B cells.
Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y, van der Geest K, Huckriede A, van Baarle D, Brouwer E Nat Rev Rheumatol. 2023; 19(9):560-575.
PMID: 37438402 DOI: 10.1038/s41584-023-00992-8.
Impaired migratory phenotype of CD4 T cells in Parkinson's disease.
Mamula D, Khosousi S, He Y, Lazarevic V, Svenningsson P NPJ Parkinsons Dis. 2022; 8(1):171.
PMID: 36496415 PMC: 9741605. DOI: 10.1038/s41531-022-00438-0.
Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health.
Peckham H, Webb K, Rosser E, Butler G, Ciurtin C Front Med (Lausanne). 2022; 9:909789.
PMID: 35911383 PMC: 9329564. DOI: 10.3389/fmed.2022.909789.
Liu S, Li Y, Li J, Wang S, Ji P, Zhang M Mediators Inflamm. 2022; 2022:9968847.
PMID: 35095344 PMC: 8799362. DOI: 10.1155/2022/9968847.
Liu X, Lin J, Wu H, Wang Y, Xie L, Wu J Front Pharmacol. 2021; 12:733902.
PMID: 34707498 PMC: 8543062. DOI: 10.3389/fphar.2021.733902.